Page 2379 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 143 Mechanical Interventions in Arterial and Venous Thrombosis 2121

10. Working Party on Thrombolysis in the Management of Limb Ischemia: 22. Mewissen MW, Seabrook GR, Meissner MH, et al: Catheter-directed
Thrombolysis in the management of lower limb peripheral arterial thrombolysis for lower extremity deep venous thrombosis: report of a
occlusion–a consensus document. J Vasc Interv Radiol 14:S337–S349, national multicenter registry. Radiology 211:39–49, 1999.
2003. 23. Enden T, Haig Y, Klow N, et al: Long-term outcomes after additional
11. Ouriel K, Veith FJ, Sasahara AA: A comparison of recombinant urokinase catheter-directed thrombolysis versus standard treatment for acute
with vascular surgery as initial treatment for acute arterial occlusion of iliofemoral deep vein thrombosis (the CaVenT study): a randomised
the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investiga- controlled trial. Lancet 379:31–38, 2012.
tors. N Engl J Med 338:1105–1111, 1998. 24. Vedantham S, Goldhaber SZ, Kahn SR, et al: Rationale and design
12. Ouriel K, Shortell CK, DeWeese JA, et al: A comparison of thrombolytic of the ATTRACT Study: a multicenter randomized trial to evaluate
therapy with operative revascularization in the initial treatment of acute pharmacomechanical catheter-directed thrombolysis for the prevention
peripheral arterial ischemia. J Vasc Surg 19:1021–1030, 1994. of postthrombotic syndrome in patients with proximal deep vein throm-
13. The STILE Investigators: Results of a prospective randomized trial evalu- bosis. Am Heart J 165(4):523–553, 2013.
ating surgery versus thrombolysis for ischemia of the lower extremity. 25. Jaff MR, McMurtry MS, Archer SL, et al: Management of massive and
The STILE trial. Ann Surg 220:251–266, discussion 266-268, 1994. submassive pulmonary embolism, iliofemoral deep vein thrombosis, and
14. Schernthaner MB, Samuels S, Biegler P, et al: Ultrasound-accelerated chronic thromboembolic pulmonary hypertension: a scientific statement
versus standard catheter-directed thrombolysis in 102 patients with acute from the American Heart Association. Circulation 123(16):1788–1830,
and subacute limb ischemia. J Vasc Interv Radiol 25:1149–1156, 2014. 2011.
15. Ansel GM, George BS, et al: Rheolytic thrombectomy in the man- 26. Meissner MH, Gloviczki P, Comerota AJ, et al: Early thrombus removal
agement of limb ischemia: 30-day results from a multicenter registry. strategies for acute deep venous thrombosis: clinical practice guidelines
J Endovasc Ther 9(4):395–402, 2002. of the Society for Vascular Surgery and the American Venous Forum.
16. Anset GM, Botti CF, Jr, Silver MJ: Treatment of acute limb ischemia J Vasc Surg 55(5):1449–1462, 2012.
with a percutaneous mechanical thrombectomy-based endovascular 27. National Clinical Guideline Centre: The Management of Venous Throm-
approach: 5-year limb salvage and survival results from a single center boembolic Diseases and the Role of Thrombophilia Testing. Clinical guideline
series. Cathet Cardiovasc Interv 72(3):325–330, 2008. - methods, evidence, and recommendations, London, June 2012, Royal
17. Daly B, Patel M, Prasad A: The use of the Trellis-6 thrombectomy device College of Physicians.
in the management acute limb ischemia due to native vessel occlusion: 28. Kahn SR, Comerota AJ, Cushman M, et al: The post-thrombotic syn-
challenges, tips, and limitations. Cathet Cardiovasc Interv 81:42–47, drome: evidence-based prevention, diagnosis, and treatment strategies:
2013. a scientific statement from the American Heart Association. Circulation
18. Kearon C, Akl EA, Ornelas J, et al: Antithrombotic therapy for VTE: 130(18):1636–1661, 2014.
CHEST guideline and expert panel report. Chest 149:315–352, 2016. 29. Raju S, Neglen P: Percutaneous recanalization of total occlusions of the
19. Mantha S, Ansell J: Indirect comparison of dabigatran, rivaroxaban, iliac vein. J Vasc Surg 50:360–368, 2009.
apixaban and edoxaban for treatment of acute venous thromboembolism. 30. The PREPIC Study Group: Eight-year follow-up of patients with
J Thromb Thrombolysis 39:155–165, 2015. permanent vena cava filters in the prevention of pulmonary embolism.
20. Kahn SR, Shrier I, Julian JA, et al: Determinants and time course of Circulation 112:416–422, 2005.
the postthrombotic syndrome after acute deep venous thrombosis. Ann 31. Mismetti P, Laporte S, Pellerin O, et al: Effect of a retrievable inferior
Intern Med 149:698–707, 2008. vena cava filter plus anticoagulation vs anticoagulation alone on risk
21. Kahn SR, Shbaklo H, Lamping DL, et al: Determinants of health- of recurrent pulmonary embolism: a randomized clinical trial. JAMA
related quality of life during the 2 years following deep vein thrombosis. 313(16):1627–1635, 2015.
J Thromb Haemost 6:1105–1112, 2008.